Latest from ESMO congresses
The ESMO Daily Reporter is the official ESMO newspaper providing live reporting, highlights, critical insights on data presented at ESMO congresses, and expert opinions on controversial topics.
Newsroom
Read the latest news and updates from ESMO and the oncology community
Resources for Media
For media interested in reporting on cancer issues, check for the latest press releases and press briefings, abstract announcements, embargo policies, meeting information and tailored resources.
Colorectal cancer: guided by the gut?
A focus on the latest research in targeting cancer microbiome
Society Updates
Recipients of the 2022 ESMO Society Awards Announced
ESMO has announced today the winners of the 2022 ESMO Society Awards.
New Executive Board members elected
ESMO has announced today the results of its Executive Board elections following the closure of the voting system on Monday 27 June 2022.
Covid and Cancer Portal
Latest news and resources to tackle the pandemic era
Oncology News
EMA Recommends Granting a Marketing Authorisation for Nivolumab / Relatlimab
It is indicated for the first-line treatment of advanced melanoma in adults and adolescents 12 years of age and older with tumour cell PD-L1 expression < 1%
Neoadjuvant Niraparib Demonstrates Promising Antitumour Activity and Safety in Patients with Localised HER2-negative, BRCA-mutated Breast Cancer
Findings from the single-arm, phase II study
Trastuzumab Deruxtecan Shows High Intracranial Response Rate in Patients with Active Brain Metastases from HER2-positive Breast Cancer
Findings from the TUXEDO-1 study